Delivery Order SPE2DB25D3404-SPE2DB26FULYM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,997.91 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 30, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for teriparatide 560 mcg/2.24 mL pen injections, valued at $5,592.67 with a firm fixed price structure. The award, issued on August 22, 2025, with completion targeted for August 25, 2025, represents a non-set-aside competitive award for pharmaceutical supply fulfillment. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $2,691.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for October 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion prime vendor agreement...
- The Defense Logistics Agency awarded a delivery order valued at $4,894.36 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. The contract, which was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $90,086.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Teriparatide 560 mcg/2.24 ml pens with a completion date of June 4, 2025. This contract utilizes no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026. The...
- The Defense Logistics Agency awarded a $7,010.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24mL pen pharmaceutical products, with an ultimate completion date of November 6, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,422.77 to AmerisourceBergen Drug Corp for Teriparatide 560 MCG/2.24 ML pen injections on August 18, 2025, with a completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,074.72 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform at its corporate office location in the same city....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,758.48 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULYMDelivery Order
The Defense Logistics Agency awarded a $5,730.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560MCG/2.24ML pen injectors, with an ultimate completion date of November 5, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for the Defense Health Agency and military healthcare systems worldwide. The product being delivered—Teriparatide—is a synthetic human parathyroid hormone used to treat osteoporosis in postmenopausal women and men at high risk for fractures, reflecting the pharmaceutical distributor's role in supporting military and veteran healthcare needs across multiple therapeutic domains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and a critical vendor for federal medical procurement. The company's DLA prime vendor agreement encompasses a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities. This particular delivery order represents a routine transaction under that larger contract vehicle, consistent with AmerisourceBergen's established pattern of fulfilling federal medical supply requirements through competitively awarded, firm fixed-price arrangements with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 11/4/25 |